|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Noreen F, Röösli M, Gaj P, Pietrzak J,
Weis S, Urfer P, Regula J, Schär P and Truninger K: Modulation of
age- and cancer-associated DNA methylation change in the healthy
colon by aspirin and lifestyle. J Natl Cancer Inst. 106(pii):
dju1612014.PubMed/NCBI
|
|
3
|
Pelser C, Arem H, Pfeiffer RM, Elena JW,
Alfano CM, Hollenbeck AR and Park Y: Prediagnostic lifestyle
factors and survival after colon and rectal cancer diagnosis in the
National Institutes of Health (NIH)-AARP diet and health study.
Cancer. 120:1540–1547. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang W, Liu Z, Zhou G, Tian A and Sun N:
Magnetic gold nanoparticle-mediated small interference RNA
silencing Bag-1 gene for colon cancer therapy. Oncol Rep.
35:978–984. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hay ED: The mesenchymal cell, its role in
the embryo, and the remarkable signaling mechanisms that create it.
Dev Dyn. 233:706–720. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao JH, Luo Y, Jiang YG, He DL and Wu CT:
Knockdown of β-catenin through shRNA cause a reversal of EMT and
metastatic phenotypes induced by HIF-1α. Cancer Invest. 29:377–382.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang Y, Shi J, Chai K, Ying X and Zhou BP:
The role of Snail in EMT and tumorigenesis. Curr Cancer Drug
Targets. 13:963–972. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Reinacher-Schick A, Baldus SE, Romdhana B,
Landsberg S, Zapatka M, Mönig SP, Hölscher AH, Dienes HP, Schmiegel
W and Schwarte-Waldhoff I: Loss of Smad4 correlates with loss of
the invasion suppressor E-cadherin in advanced colorectal
carcinomas. J Pathol. 202:412–420. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu CY, Tsai YP, Wu MZ, Teng SC and Wu KJ:
Epigenetic reprogramming and post-transcriptional regulation during
the epithelial-mesenchymal transition. Trends Genet. 28:454–463.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Z, Yao L, Yang J, Wang Z and Du G:
PI3K/Akt and HIF-1 signaling pathway in hypoxiaischemia (Review).
Mol Med Rep. 18:3547–3554. 2018.PubMed/NCBI
|
|
11
|
Miyoshi K and Hennighausen L:
Beta-catenin: A transforming actor on many stages. Breast Cancer
Res. 5:63–68. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Maruyama K, Ochiai A, Akimoto S, Nakamura
S, Baba S, Moriya Y and Hirohashi S: Cytoplasmic beta-catenin
accumulation as a predictor of hematogenous metastasis in human
colorectal cancer. Oncology. 59:302–309. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou W, Li Y, Gou S, Xiong J, Wu H, Wang
C, Yan H and Liu T: MiR-744 increases tumorigenicity of pancreatic
cancer by activating Wnt/β-catenin pathway. Oncotarget.
6:37557–37569. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Margariti A, Zampetaki A, Xiao Q, Zhou B,
Karamariti E, Martin D, Yin X, Mayr M, Li H, Zhang Z, et al:
Histone deacetylase 7 controls endothelial cell growth through
modulation of beta-catenin. Circ Res. 106:1202–1211. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jia S, Qu T, Wang X, Feng M, Yang Y, Feng
X, Ma R, Li W, Hu Y, Feng Y, et al: KIAA1199 promotes migration and
invasion by Wnt/β-catenin pathway and MMPs mediated EMT progression
and serves as a poor prognosis marker in gastric cancer. PLoS One.
12:e01750582017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen WN and Zhu GJ: Progress in the
research of stanniocalcin. Sheng Li Ke Xue Jin Zhan. 39:225–228.
2008.(In Chinese). PubMed/NCBI
|
|
17
|
Chang AC, Jellinek DA and Reddel RR:
Mammalian stanniocalcins and cancer. Endocr Relat Cancer.
10:359–373. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yeung BH, Law AY and Wong CK: Evolution
and roles of stanniocalcin. Mol Cell Endocrinol. 349:272–280. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Karagiannis GS, Berk A, Dimitromanolakis A
and Diamandis EP: Enrichment map profiling of the cancer invasion
front suggests regulation of colorectal cancer progression by the
bone morphogenetic protein antagonist, gremlin-1. Mol Oncol.
7:826–839. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Arigami T, Uenosono Y, Ishigami S,
Yanagita S, Hagihara T, Haraguchi N, Matsushita D, Hirahara T,
Okumura H, Uchikado Y, et al: Clinical significance of
stanniocalcin 2 expression as a predictor of tumor progression in
gastric cancer. Oncol Rep. 30:2838–2844. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Coulson-Gilmer C, Humphries MP, Sundara
Rajan S, Droop A, Jackson S, Condon A, Cserni G, Jordan LB, Jones
LJ, Kanthan R, et al: Stanniocalcin 2 expression is associated with
a favourable outcome in male breast cancer. J Pathol Clin Res.
4:241–249. 2018. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Parris TZ, Kovacs A, Aziz L, Hajizadeh S,
Nemes S, Semaan M, Forssell-Aronsson E, Karlsson P and Helou K:
Additive effect of the AZGP1, PIP, S100A8 and UBE2C molecular
biomarkers improves outcome prediction in breast carcinoma. Int J
Cancer. 134:1617–1629. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hashemzadeh S, Arabzadeh AA, Estiar MA,
Sakhinia M, Mesbahi N, Emrahi L, Ghojazadeh M and Sakhinia E:
Clinical utility of measuring expression levels of Stanniocalcin 2
in patients with colorectal cancer. Med Oncol. 31:2372014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen B, Zeng X, He Y, Wang X, Liang Z, Liu
J, Zhang P, Zhu H, Xu N and Liang S: STC2 promotes the
epithelial-mesenchymal transition of colorectal cancer cells
through AKT-ERK signaling pathways. Oncotarget. 7:71400–71416.
2016.PubMed/NCBI
|
|
27
|
Ieta K, Tanaka F, Yokobori T, Kita Y,
Haraguchi N, Mimori K, Kato H, Asao T, Inoue H, Kuwano H and Mori
M: Clinicopathological significance of stanniocalcin 2 gene
expression in colorectal cancer. Int J Cancer. 125:926–931. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Miyazaki S, Kikuchi H, Iino I, Uehara T,
Setoguchi T, Fujita T, Hiramatsu Y, Ohta M, Kamiya K, Kitagawa K,
et al: Anti-VEGF antibody therapy induces tumor hypoxia and
stanniocalcin 2 expression and potentiates growth of human colon
cancer xenografts. Int J Cancer. 135:295–307. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Leve F, Peres-Moreira RJ, Binato R,
Abdelhay E and Morgado-Diaz JA: LPA Induces colon cancer cell
proliferation through a cooperation between the ROCK and STAT-3
pathways. PLoS One. 10:e01390942015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yoshida GJ: Metabolic reprogramming: The
emerging concept and associated therapeutic strategies. J Exp Clin
Cancer Res. 34:1112015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang J and Sun X: MicroRNA-375 inhibits
the proliferation, migration and invasion of kidney cancer cells by
triggering apoptosis and modulation of PDK1 expression. Environ
Toxicol Pharmacol. 62:227–233. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chu GC and Chung LW: RANK-mediated
signaling network and cancer metastasis. Cancer Metastasis Rev.
33:497–509. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Probst OC, Karayel E, Schida N, Nimmerfall
E, Hehenberger E, Puxbaum V and Mach L: The mannose
6-phosphate-binding sites of M6P/IGF2R determine its capacity to
suppress matrix invasion by squamous cell carcinoma cells. Biochem
J. 451:91–99. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kitamura T and Taketo MM: Keeping out the
bad guys: Gateway to cellular target therapy. Cancer Res.
67:10099–10102. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Škovierová H, Okajčeková T, Strnádel J,
Vidomanová E and Halašová E: Molecular regulation of
epithelial-to-mesenchymal transition in tumorigenesis (Review). Int
J Mol Med. 41:1187–1200. 2018.PubMed/NCBI
|
|
36
|
Gurzu S, Silveanu C, Fetyko A, Butiurca V,
Kovacs Z and Jung I: Systematic review of the old and new concepts
in the epithelial-mesenchymal transition of colorectal cancer.
World J Gastroenterol. 22:6764–6775. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Vincan E, Brabletz T, Faux MC and Ramsay
RG: A human three-dimensional cell line model allows the study of
dynamic and reversible epithelial-mesenchymal and
mesenchymal-epithelial transition that underpins colorectal
carcinogenesis. Cells Tissues Organs. 185:20–28. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen X, Halberg RB, Burch RP and Dove WF:
Intestinal adenomagenesis involves core molecular signatures of the
epithelial-mesenchymal transition. J Mol Histol. 39:283–294. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Han X, Fang X, Lou X, Hua D, Ding W, Foltz
G, Hood L, Yuan Y and Lin B: Silencing SOX2 induced
mesenchymal-epithelial transition and its expression predicts liver
and lymph node metastasis of CRC patients. PLoS One. 7:e413352012.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
He Q, Li H, Meng F, Sun X, Feng X, Chen J,
Li L and Liu J: Methionine sulfoxide reductase B1 regulates
hepatocellular carcinoma cell proliferation and invasion via the
mitogen-activated protein kinase pathway and epithelial-mesenchymal
transition. Oxid Med Cell Longev. 2018:52879712018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ryu ES, Kim MJ, Shin HS, Jang YH, Choi HS,
Jo I, Johnson RJ and Kang DH: Uric acid-induced phenotypic
transition of renal tubular cells as a novel mechanism of chronic
kidney disease. Am J Physiol Renal Physiol. 304:F471–F480. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lemieux E, Bergeron S, Durand V, Asselin
C, Saucier C and Rivard N: Constitutively active MEK1 is sufficient
to induce epithelial-to-mesenchymal transition in intestinal
epithelial cells and to promote tumor invasion and metastasis. Int
J Cancer. 125:1575–1586. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Park KS, Kim SJ, Kim KH and Kim JC:
Clinical characteristics of TIMP2, MMP2, and MMP9 gene
polymorphisms in colorectal cancer. J Gastroenterol Hepatol.
26:391–397. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Fu W, Tao T, Qi M, Wang L, Hu J, Li X,
Xing N, Du R and Han B: MicroRNA-132/212 upregulation inhibits
TGF-β-mediated epithelial-mesenchymal transition of prostate cancer
cells by targeting SOX4. Prostate. 76:1560–1570. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang JX, Zhai JF, Yang XT and Wang J:
MicroRNA-132 inhibits migration, invasion and
epithelial-mesenchymal transition by regulating TGFβ1/Smad2 in
human non-small cell lung cancer. Eur Rev Med Pharmacol Sci.
20:3793–3801. 2016.PubMed/NCBI
|
|
46
|
Teichroeb JH, Kim J and Betts DH: The role
of telomeres and telomerase reverse transcriptase isoforms in
pluripotency induction and maintenance. RNA Biol. 13:707–719. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kim HJ, Moon SJ, Kim SH, Heo K and Kim JH:
DBC1 regulates Wnt/β-catenin-mediated expression of MACC1, a key
regulator of cancer progression, in colon cancer. Cell Death Dis.
9:8312018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Li X, Hu W, Zhou J, Huang Y, Peng J, Yuan
Y, Yu J and Zheng S: CLCA1 suppresses colorectal cancer
aggressiveness via inhibition of the Wnt/beta-catenin signaling
pathway. Cell Commun Signal. 15:382017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Han X, Zheng J, Wang Y and Gao Z:
miRNA-29a inhibits colon cancer growth by regulation of the
PTEN/Akt/GSK3β and Wnt/β-catenin signaling pathways. Oncol Lett.
16:2638–2644. 2018.PubMed/NCBI
|
|
50
|
Zhang Y, Seid K, Obermayr F, Just L and
Neckel PH: Activation of Wnt signaling increases numbers of enteric
neurons derived from neonatal mouse and human progenitor cells.
Gastroenterology. 153:154–165.e9. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Mao D, Qiao L, Lu H and Feng Y: B-cell
translocation gene 3 overexpression inhibits proliferation and
invasion of colorectal cancer SW480 cells via Wnt/β-catenin
signaling pathway. Neoplasma. 63:705–716. 2016. View Article : Google Scholar : PubMed/NCBI
|
